Disease & disorder

Graham-Boyle-Troxell syndrome

MONDO:0023275

Cystic hamartoma of lung and kidney is a rare developmental malformation reported in 3 patients characterized by the presence of benign hamartomatous cysts in kidney and lung, clinically presenting as abdominal mass. Others associated features include hyperplastic nephromegaly, medullary dysplasia and mesoblastic nephroma. There have been no further descriptions in the literature since 1987.

Clinical trials0
Recruiting0
Drug concepts studied0
Synonyms4

Research intelligence

Directly mapped studies only · unique clinical trials

Current registry observations. Phase counts may overlap. Study start dates are not registry registration dates. Investigational interventions are not approved-treatment recommendations.

Medications under investigation

Verified disease and drug mappings that co-occur within the same study; not evidence of effectiveness.

Loading mapped interventions…

MONDO disease family

Loading verified ontology relationships…

Recruiting studies by city

Loading research-site locations…

Trial status

Loading…

Trial phase

Loading…

Study start year

Loading…

Investigated drug interventions

Loading…
Background context

Graham–Boyle–Troxell syndrome

Graham-Boyle-Troxell syndrome, also known as Cystic hamartoma of the lung and kidney, is an extremely rare congenital malformation which is characterized by benign hamartomatous cysts present in the lung and kidney. Symptoms include respiratory insufficiency, recurrent respiratory infections, and hypertension. Additional radiological features include hyperplastic nephromegaly, dysplastic medulla, and mesoblastic nephroma. Only three cases have been described in medical literature. Its inheritance pattern is not known.

Background only. Canonical identity remains MONDO; clinical-trial relationships come from ClinicalTrials.gov.

Drugs being studied

Disease identity and terminology: MONDO. Trial relationships: ClinicalTrials.gov.